<DOC>
	<DOC>NCT02139410</DOC>
	<brief_summary>Insulin-like growth factor 1 (IGF)-1 is an important neuromyotrophic hormone. Disregulation of this hormone has been reported to influence the genesis of cognitive impairment and dementia in the elderly patients. We analyzed the possible link between IGF-1 and risk of Sarcopenia and Mortality in a cohort of elder patients with cognitive impairment.</brief_summary>
	<brief_title>IGF-1, Sarcopenia and Mortality: a Cohort Study in Patient With Cognitive Impairment</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Sarcopenia</mesh_term>
	<criteria>Diagnosis of cognitive impairment (MMSE &lt; 24) Age &gt; 65 ys Diagnosis of pancreatic disorders Diagnosis of acromegaly Diagnosis of GHrelated disorders Recent bone fractures or immobility before the enrollment (3 months) Cancer</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>sarcopenia</keyword>
	<keyword>mortality</keyword>
</DOC>